Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload.

Montes-Cobos E, Li X, Fischer HJ, Sasse A, Kügler S, Didié M, Toischer K, Fassnacht M, Dressel R, Reichardt HM.

PLoS One. 2015 Nov 25;10(11):e0143954. doi: 10.1371/journal.pone.0143954. eCollection 2015.

2.

RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension.

Sun Z, Bello-Roufai M, Wang X.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1880-7. doi: 10.1152/ajpheart.01319.2007. Epub 2008 Feb 22.

3.

Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.

Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M.

Hypertension. 2006 Apr;47(4):656-64. Epub 2006 Feb 27.

PMID:
16505208
4.

Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, Jaisser F.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):7160-5. Epub 2002 May 7.

5.

Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.

Hubert C, Gasc JM, Berger S, Schütz G, Corvol P.

Mol Endocrinol. 1999 Feb;13(2):297-306.

PMID:
9973259
6.

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ.

Kidney Int. 2012 Sep;82(6):643-51. doi: 10.1038/ki.2012.170. Epub 2012 May 23.

7.

The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels.

van Leeuwen N, Caprio M, Blaya C, Fumeron F, Sartorato P, Ronconi V, Giacchetti G, Mantero F, Fernandes-Rosa FL, Simian C, Peyrard S, Zitman FG, Penninx BW, de Kloet ER, Azizi M, Jeunemaitre X, Derijk RH, Zennaro MC.

Hypertension. 2010 Nov;56(5):995-1002. doi: 10.1161/HYPERTENSIONAHA.110.155630. Epub 2010 Sep 20.

PMID:
20855654
8.

Role of hypothalamic angiotensin type 1 receptors in pressure overload-induced mineralocorticoid receptor activation and salt-induced sympathoexcitation.

Ito K, Hirooka Y, Nakano M, Honda N, Matsukawa R, Sunagawa K.

Hypertens Res. 2013 Jun;36(6):513-9. doi: 10.1038/hr.2012.221. Epub 2013 Jan 31.

PMID:
23364339
9.

Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.

Tordjman KM, Semenkovich CF, Coleman T, Yudovich R, Bak S, Osher E, Vechoropoulos M, Stern N.

Hypertension. 2007 Nov;50(5):945-51. Epub 2007 Oct 1.

PMID:
17909121
10.

Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure.

Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ.

Hypertension. 2014 May;63(5):1033-40. doi: 10.1161/HYPERTENSIONAHA.113.01803. Epub 2014 Feb 24.

PMID:
24566081
11.

Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.

Bienvenu LA, Morgan J, Rickard AJ, Tesch GH, Cranston GA, Fletcher EK, Delbridge LM, Young MJ.

Endocrinology. 2012 Jul;153(7):3416-25. doi: 10.1210/en.2011-2098. Epub 2012 May 31.

PMID:
22653557
12.

Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates.

Martinerie L, Viengchareun S, Delezoide AL, Jaubert F, Sinico M, Prevot S, Boileau P, Meduri G, Lombès M.

Endocrinology. 2009 Sep;150(9):4414-24. doi: 10.1210/en.2008-1498. Epub 2009 May 28.

13.

Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.

Stas S, Whaley-Connell A, Habibi J, Appesh L, Hayden MR, Karuparthi PR, Qazi M, Morris EM, Cooper SA, Link CD, Stump C, Hay M, Ferrario C, Sowers JR.

Endocrinology. 2007 Aug;148(8):3773-80. Epub 2007 May 10.

PMID:
17494996
14.

Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

Shibata H, Itoh H.

Am J Hypertens. 2012 May;25(5):514-23. doi: 10.1038/ajh.2011.245. Epub 2012 Jan 19. Review.

PMID:
22258336
15.

Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.

Ehsan A, McGraw AP, Aronovitz MJ, Galayda C, Conte MS, Karas RH, Jaffe IZ.

J Thorac Cardiovasc Surg. 2013 Jun;145(6):1642-9, 1649.e1. doi: 10.1016/j.jtcvs.2012.08.007. Epub 2012 Sep 13.

16.

Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors.

Pruthi D, McCurley A, Aronovitz M, Galayda C, Karumanchi SA, Jaffe IZ.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):355-64. doi: 10.1161/ATVBAHA.113.302854. Epub 2013 Dec 5.

17.

Rescue of the mineralocorticoid receptor knock-out mouse.

Bleich M, Warth R, Schmidt-Hieber M, Schulz-Baldes A, Hasselblatt P, Fisch D, Berger S, Kunzelmann K, Kriz W, Schütz G, Greger R.

Pflugers Arch. 1999 Aug;438(3):245-54.

PMID:
10398852
18.

Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.

Ma Y, Chen Y, Yang Y, Chen B, Liu D, Xiong Z, Zhang C, Dong Y.

Biochem Pharmacol. 2013 Jan 15;85(2):223-33. doi: 10.1016/j.bcp.2012.10.025. Epub 2012 Nov 8.

PMID:
23142711
19.

Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell Activation.

Li C, Sun XN, Zeng MR, Zheng XJ, Zhang YY, Wan Q, Zhang WC, Shi C, Du LJ, Ai TJ, Liu Y, Liu Y, Du LL, Yi Y, Yu Y, Duan SZ.

Hypertension. 2017 Jul;70(1):137-147. doi: 10.1161/HYPERTENSIONAHA.117.09070. Epub 2017 May 30.

PMID:
28559389
20.

Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.

Kawarazaki W, Fujita T.

Clin Exp Pharmacol Physiol. 2013 Dec;40(12):929-36. doi: 10.1111/1440-1681.12177. Review.

PMID:
24111570

Supplemental Content

Support Center